Carlisle Companies Stock Intrinsic Value – Dixon Mitchell Investment Counsel reduces stake in Carlisle Companies by 28.1% in 4th quarter

April 4, 2024

🌥️Trending News

Carlisle Companies ($NYSE:CSL) is a multi-industry company that specializes in manufacturing and distributing a wide range of products across various markets, including construction, agriculture, aerospace, and healthcare. With a strong reputation for innovation and quality, Carlisle Companies has been a popular choice for many investors over the years. Its stock is listed on the New York Stock Exchange under the ticker symbol CSL and has consistently performed well, making it an attractive investment opportunity.

However, in the 4th quarter of the fiscal year, Dixon Mitchell Investment Counsel Inc., a Vancouver-based investment management firm, made a significant move by reducing its stake in Carlisle Companies. The firm sold off 28.1% of its shares in the company, resulting in a decrease in its ownership. While the exact reasons behind this decision are not disclosed, it certainly raises questions about the firm’s confidence in the company’s future prospects. One possible explanation for this reduction in stake could be related to the current state of the global economy. Furthermore, with Carlisle Companies’ stock price reaching an all-time high in the 4th quarter, it is possible that Dixon Mitchell Investment Counsel Inc. saw an opportunity to capitalize on its investment and lock in profits. It will be interesting to see how this reduction in stake will impact the company’s stock performance and if other investors will follow suit in the coming quarters.

Analysis – Carlisle Companies Stock Intrinsic Value

After conducting a thorough analysis of CARLISLE COMPANIES, I have identified some key points that potential investors should be aware of. Firstly, it is important to note that our proprietary Valuation Line suggests that the intrinsic value of CARLISLE COMPANIES shares is around $314.3. This means that based on the company’s fundamentals, its true value is significantly lower than its current trading price. Furthermore, it is worth mentioning that CARLISLE COMPANIES stock is currently being traded at $391.8, which indicates that it is overvalued by approximately 24.7%. This could be a cause for concern for investors, as they may end up paying a premium for a company that is not worth its current market value. From a fundamental standpoint, CARLISLE COMPANIES does have some strong points. The company operates in the industrial sector and has a diverse portfolio of products and services. They also have a solid financial track record, with consistent revenue growth and profitability. However, it is important to consider the potential risks associated with investing in CARLISLE COMPANIES. One factor to consider is the current economic climate, which could impact the demand for their products and services. Additionally, the company operates in a highly competitive market, which could affect their market share and profitability. In conclusion, while CARLISLE COMPANIES has some positive aspects, it is important for investors to carefully evaluate the stock’s valuation and consider the potential risks before making an investment decision. At its current trading price, CARLISLE COMPANIES appears to be overvalued, and it may be wise to wait for a more favorable entry point before investing in the company. More…

  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Carlisle Companies. More…

    Total Revenues Net Income Net Margin
    4.59k 767.4 15.7%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Carlisle Companies. More…

    Operations Investing Financing
    1.2k 352.4 -1.35k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Carlisle Companies. More…

    Total Assets Total Liabilities Book Value Per Share
    6.82k 3.89k 60.06
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Carlisle Companies are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    2.6% 26.7% 21.9%
    FCF Margin ROE ROA
    23.1% 21.5% 9.2%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items




  • Peers

    The company operates in three segments: Carlisle Construction Materials, Carlisle Interconnect Technologies, and Carlisle Brake & Friction. Schweiter Technologies AG, Forbo Holding AG, and Sankyo Tateyama Inc. are all competitors of Carlisle Companies Inc.

    – Schweiter Technologies AG ($OTCPK:SCWTF)

    Schweiter Technologies AG is a publicly traded company with a market capitalization of 1.03 billion as of 2022. The company has a return on equity of 7.24%. Schweiter Technologies AG is engaged in the development, manufacture and marketing of textile machines, precision tools and related services. The company’s products are used in the textile, automotive, aerospace and other industries.

    – Forbo Holding AG ($LTS:0QKD)

    Forbo Holding AG is a Swiss manufacturer of floor coverings, adhesives and other specialty products. The company has a market capitalization of 1.77 billion as of 2022 and a return on equity of 21.17%. Forbo produces a wide range of products for both commercial and residential applications, including vinyl and linoleum flooring, carpet tiles, adhesives, sealants and coatings. The company has a strong presence in Europe and Asia, and is expanding its operations in North America and South America.

    – Sankyo Tateyama Inc ($TSE:5932)

    Sankyo Tateyama Inc is a Japanese company that manufactures and sells pharmaceuticals and medical devices. The company has a market cap of 17.4 billion as of 2022 and a return on equity of 0.94%. The company’s products include drugs for the treatment of hypertension, diabetes, and dyslipidemia, as well as medical devices such as blood pressure monitors and glucose meters.

    Summary

    Dixon Mitchell Investment Counsel Inc. has reduced its stake in Carlisle Companies Incorporated by 28.1%, a significant decrease in their holdings. This move by the investment firm suggests that they have conducted a thorough analysis of the company’s performance, financials, and market trends and have come to the conclusion that it may not be a lucrative investment at this time. This could be due to various factors such as declining sales, weak financials, or unfavorable market conditions.

    Recent Posts

    Leave a Comment